Skip to main content

Table 3 Comparison of studied parameters between our study and the only other study on RBM3 in urothelial carcinoma

From: Evaluation of RNA-binding motif protein 3 expression in urothelial carcinoma of the bladder: an immunohistochemical study

  Current study Boman et al. [18]
Specimen type and tumor stagea Cystectomies Bladder biopsies
Transurethral resections of bladder tumors (TURBTs)
Distribution of high-grade disease 274/274 (100 %) 261/343 (76 %)
Categorization of patient groups Tumor stage  
Lymph node involvement Tumor stage
Lymphovascular invasion Tumor grade
Surgical resection margin status  
RBM3 IHC scoring H-score (continuous variable) Dichotomized and trichotomized nuclear scores
  1. aPatients undergoing cystectomy for urothelial carcinoma have a worse prognosis due to muscle-invasive (higher stage) disease compared to patients who can initially be managed medically (intravesicular bacillus Calmette-Guerin treatment) based on biopsy or TURBT results (non-muscle-invasive or lower stage disease)